Scientists test if meals change how body handles new mental health pill
NCT ID NCT07292233
Summary
This early-stage study aims to understand how eating food affects how the body absorbs and processes a new extended-release tablet (LY03020) being developed for schizophrenia and Alzheimer's disease psychosis. It involves 16 healthy volunteers who will take a single dose of the drug both with and without food. The main goal is to measure drug levels in the blood to see if food changes them, while also checking for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing AnDing Hospital Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.